Trails Edge Capital Partners, Lp Portfolio Stock Holdings
Trails Edge Capital Partners, Lp disclosed 26 stock positions valued at approximately $424.9 million in its latest SEC 13F filing. The largest holdings include VAXCYTE INC, MIRUM PHARMACEUTICALS INC, and NURIX THERAPEUTICS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 26
- Portfolio Value
- $424.9M
Holdings by Sector
Trails Edge Capital Partners, Lp Portfolio Holdings in Q1 2026
18 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| VAXCYTE INC | PCVX | Healthcare | 9.06% | 662,470 | -75,000 | -10.17% | $38,496,132 |
| MIRUM PHARMACEUTICALS INC | MIRM | Healthcare | 7.25% | 333,312 | +301,450 | +946.11% | $30,791,363 |
| NURIX THERAPEUTICS INC | NRIX | Healthcare | 6.36% | 1,743,220 | - | - | $27,019,910 |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 6.02% | 440,000 | -157,092 | -26.31% | $25,586,000 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 5.61% | 245,000 | +245,000 | +100.00% | $23,826,250 |
| ARCUS BIOSCIENCES INC | RCUS | Healthcare | 5.33% | 1,047,935 | +131,622 | +14.36% | $22,635,396 |
| IMMUNOCORE HLDGS PLC | IMCR | Healthcare | 4.84% | 682,597 | - | - | $20,580,300 |
| CYTOKINETICS INC | CYTK | Healthcare | 4.65% | 300,000 | +300,000 | +100.00% | $19,773,000 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 3.86% | 701,821 | +701,821 | +100.00% | $16,394,539 |
| NEUROGENE INC | NGNE | Healthcare | 3.71% | 782,787 | -2,213 | -0.28% | $15,780,986 |
| INHIBIKASE THERAPEUTICS INC | IKT | Healthcare | 3.19% | 8,057,345 | +1,879,221 | +30.42% | $13,536,340 |
| 4D MOLECULAR THERAPEUTICS IN | FDMT | Healthcare | 2.85% | 1,302,917 | +1,302,917 | +100.00% | $12,130,157 |
| IMMUNOVANT INC | IMVT | Healthcare | 2.42% | 414,054 | +173,889 | +72.40% | $10,285,102 |
| DESIGN THERAPEUTICS INC | DSGN | Healthcare | 2.13% | 852,013 | +852,013 | +100.00% | $9,065,418 |
| MINERVA NEUROSCIENCES INC | NERV | Healthcare | 2.01% | 1,419,000 | +1,419,000 | +100.00% | $8,549,475 |
| CENTURY THERAPEUTICS INC | IPSC | Healthcare | 1.30% | 2,449,993 | +2,449,993 | +100.00% | $5,536,984 |
| VTV THERAPEUTICS INC | VTVT | Healthcare | 1.30% | 139,578 | -91,422 | -39.58% | $5,535,663 |
| OPUS GENETICS INC | OCUP | Other | 0.54% | 500,000 | +500,000 | +100.00% | $2,275,000 |
Trails Edge Capital Partners, Lp Options Holdings in Q1 2026
1 options positions in the latest reporting period.
Page 1 of 1
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q1 2026 | XENE | Xenon Pharmaceuticals Inc. | PUT | 200,000 | $11,630,000 |
Notional value represents the total exposure of the options position.